<--- Back to Details
First PageDocument Content
Tuberculosis / Bacillus Calmette-Guérin / Vaccines / Bladder cancer / Transitional cell carcinoma / Immunotherapy / End point of clinical trials / Cancer cell / BCG as a treatment for bladder cancer / Medicine / Oncology / Cancer treatments
Tuberculosis
Bacillus Calmette-Guérin
Vaccines
Bladder cancer
Transitional cell carcinoma
Immunotherapy
End point of clinical trials
Cancer cell
BCG as a treatment for bladder cancer
Medicine
Oncology
Cancer treatments

An upper limit for macromolecular crowding effects

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 851,86 KB

Share Document on Facebook

Similar Documents

Bladder cancer / Transitional cell carcinoma / Immunotherapy / Chemotherapy / Cancer / BCG as a treatment for bladder cancer / Mark Soloway / Medicine / Cancer treatments / Management of cancer

Administration of Intravesical Therapies Self Directed Learning Package © Department of Health, State of Western Australia[removed]Copyright to this material produced by the Western Australian Department of Health belon

DocID: VOfS - View Document

Bladder cancer / Transitional cell carcinoma / Bacillus Calmette-Guérin / Valrubicin / Cystectomy / BCG as a treatment for bladder cancer / Medicine / Oncology / Carcinoma

Microsoft PowerPoint - 643_Nemunaitis.ppt

DocID: GqLQ - View Document

Bacillus Calmette-Guérin / Cystectomy / Clinical trial / BCG as a treatment for bladder cancer / Medicine / Health / Bladder cancer

COMPARATIVE EFFECTIVENESS OF CONSERVATIVE THERAPY VS. CYSTECTOMY FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS RESULTS INTRODUCTION

DocID: qVVe - View Document

Bladder cancer / Transitional cell carcinoma / Immunotherapy / Abscess / Rifampicin / Isoniazid / Adverse effect / BCG as a treatment for bladder cancer / Medicine / Tuberculosis / Bacillus Calmette-Guérin

BCG Live Insert - Word Format

DocID: occ5 - View Document

Bacillus Calmette-Guérin / Vaccines / Bladder cancer / Carcinoma / Immunotherapy / Carcinoma in situ / BCG as a treatment for bladder cancer / Transitional cell carcinoma / Medicine / Tuberculosis / Cancer treatments

SUMMARY FOR BASIS OF APPROVAL REFERENCE NUMBER:

DocID: o2Ld - View Document